In cancer patients, an elevated level of PCT is associated with the tumor microenvironment, characterized by an inflammatory state where tumor cells and surrounding cells produce proinflammatory mediators such as TNF-α, IL-6, and IL-1 [55]. This evidence concerns the gene CALCA and cancer.